Biotech entity

CDC

organization

The clearest coverage concentration is pharma: 8 of 9 stories, with the rest divided among 1 other category. Against the same-window beat baseline of 16% negative, this entity's 44% share is more negative. GSK is the most frequent co-covered peer, appearing in 4 of the 9 tracked stories.

Last mentioned: Mar 25, 2026

Entity pulse

Recent coverage · CDC

9 stories
6.4 avg impact
11% positive
44% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 33 percentage points.

  • 11% positive
  • 44% neutral
  • 44% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about CDC

The clearest coverage concentration is pharma: 8 of 9 stories, with the rest divided among 1 other category. Against the same-window beat baseline of 16% negative, this entity's 44% share is more negative. GSK is the most frequent co-covered peer, appearing in 4 of the 9 tracked stories. Across a 116-day span, the pace is roughly 0.5 stories per week. The busiest single day carried 2. Their average consequence score of 6.4 runs above the beat's 6.1 for that window. They are less corroborated than the beat average, carrying 2.8 original sources each against 3.4 for the same window. This profile follows 9 Biotech stories mentioning CDC across the period from February 20, 2026 to June 15, 2026.

Stories tracked
9
Per week
0.5
Negative
44%
Sources per story
2.8

Computed from the 9 stories linked to this entity, with beat comparisons drawn from all 450 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering CDC. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Federal Injunction

    A federal judge issues a temporary block on the administration's vaccine agenda, citing public health risks.

  2. Expected Response

    The Trump administration is expected to file its initial legal defense regarding executive agency authority.

  3. Social media trends drive a surge in requests for surgical remains to be converted into keepsakes.

  4. Medical journals increase focus on the lack of regulation in the placenta encapsulation industry.

  5. The Conversation publishes a comprehensive analysis of the risks associated with human tissue keepsakes.

  6. Public Announcement

    Arizona and other state attorneys general publicly detail the health risks associated with the vaccine rollback.

  7. Lawsuit Filed

    A coalition of states files a formal complaint against the Trump administration in federal court.

  8. Dual-Leadership Confirmed

    International sources confirm Bhattacharya will lead both agencies, highlighting the strategic consolidation of health oversight.

  9. CDC Appointment Announced

    Reports emerge that NIH Director Dr. Jay Bhattacharya will take over as acting head of the CDC.

  10. Proposed Schedule Changes

    The administration proposes sweeping changes to the national pediatric immunization schedule.

  11. Policy Shift Initiated

    RFK Jr. begins implementing a new agenda for federal vaccine oversight and safety reviews.

  12. CDC Warning Issued

    The CDC issues a formal warning after a newborn develops sepsis from maternal placenta consumption.

Stories mentioning CDC 9

Pharma Neutral

Federal Judge Temporarily Blocks RFK Jr.’s Vaccine Policy Overhaul

A federal judge has issued a temporary injunction against Robert F. Kennedy Jr.’s proposed changes to national vaccine policy, citing potential risks to public health. The ruling provides a reprieve for pharmaceutical manufacturers and public health agencies while the legal merits of the administration's agenda are debated.

6 sources
Pharma Neutral

CDC Data Reveals Suboptimal Flu Vaccine Efficacy for 2025-2026 Season

Preliminary reports from US health officials indicate that this season's influenza vaccines provided lower-than-expected protection against circulating strains. The findings underscore the persistent challenge of viral mismatch and are expected to accelerate the industry's shift toward next-generation mRNA and recombinant vaccine technologies.

2 sources
Pharma Negative

CDC Issues Global Travel Alerts as Polio Resurges in Tourist Hubs

The CDC has issued urgent travel advisories for several popular tourist destinations following a confirmed spread of poliovirus. This development signals a significant setback for global eradication efforts and is expected to drive a surge in demand for inactivated poliovirus vaccines (IPV).

2 sources
Pharma Neutral

The Biohazard Risks of Human Tissue Keepsakes and Placentophagy

A growing trend of retaining and consuming human tissue, such as placentas and surgical remains, is raising significant biohazard and infection concerns. Medical experts warn that the lack of regulatory oversight and clinical evidence for these practices poses serious risks to public health.

2 sources
Funding Positive

US and DR Congo Ink Landmark $1.2 Billion Health Partnership Agreement

The United States and the Democratic Republic of the Congo have finalized a $1.2 billion health partnership aimed at strengthening healthcare infrastructure and disease surveillance. This multi-year commitment focuses on global health security, infectious disease control, and improving maternal and child health outcomes.

5 sources
Pharma Negative

15 States Sue Trump Administration Over Childhood Vaccine Schedule Changes

California and 14 other states have filed a federal lawsuit against the Trump administration, challenging recent modifications to the recommended childhood immunization schedule. The coalition argues that these changes lack scientific justification and threaten to undermine decades of public health progress.

2 sources
Pharma Negative

States Sue Trump Administration Over Childhood Vaccine Recommendation Rollback

A coalition of over a dozen states, led by Arizona, has filed a federal lawsuit against the Trump administration to block the rollback of childhood vaccine recommendations. The plaintiffs argue that the changes to CDC guidelines bypass scientific protocols and present an immediate threat to national public health safety.

2 sources
Pharma Neutral

Dr. Jay Bhattacharya to Lead Both NIH and CDC in Unprecedented Move

NIH Director Dr. Jay Bhattacharya has been appointed as the acting head of the CDC, creating a historic dual-leadership role over the two most powerful U.S. health agencies. This consolidation marks a significant shift in public health strategy, placing research and implementation under a single executive.

2 sources

CDC is linked from 9 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.